Fedora Pharmaceuticals

Fedora Pharmaceuticals is a biotechnology company dedicated to the discovery and development of antibiotics to meet the needs posed by life-threatening microbial resistance. The company develops β-lactamase inhibitor molecules, which are enzymes produced by bacteria that disrupt the common ring structure of β-lactam antibiotics such as penicillin derivatives, cephalosporins, monolactams, and carbapenems.